CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Clinical trial NCT00653952 · TERMINATED
Trial details
- NCT number
- NCT00653952
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-05-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.